- Home
- COSM vs RNXT Comparison
COSM vs RNXT Comparison
Compare COSM & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COSM
- RNXT
- Stock Information
- Founded
- COSM 2009
- RNXT 2012
- Country
- COSM United States
- RNXT United States
- Employees
- COSM N/A
- RNXT N/A
- Industry
- COSM Other Pharmaceuticals
- RNXT Biotechnology: Pharmaceutical Preparations
- Sector
- COSM Health Care
- RNXT Health Care
- Exchange
- COSM Nasdaq
- RNXT Nasdaq
- Market Cap
- COSM 32.3M
- RNXT 35.2M
- IPO Year
- COSM 2013
- RNXT 2021
- Fundamental
- Price
- COSM $0.75
- RNXT $0.78
- Analyst Decision
- COSM
- RNXT Strong Buy
- Analyst Count
- COSM 0
- RNXT 2
- Target Price
- COSM N/A
- RNXT $7.50
- AVG Volume (30 Days)
- COSM 462.3K
- RNXT 371.1K
- Earning Date
- COSM 11-14-2025
- RNXT 11-13-2025
- Dividend Yield
- COSM N/A
- RNXT N/A
- EPS Growth
- COSM N/A
- RNXT N/A
- EPS
- COSM N/A
- RNXT N/A
- Revenue
- COSM $55,093,442.00
- RNXT $928,000.00
- Revenue This Year
- COSM $28.14
- RNXT $2,895.35
- Revenue Next Year
- COSM N/A
- RNXT $313.04
- P/E Ratio
- COSM N/A
- RNXT N/A
- Revenue Growth
- COSM N/A
- RNXT N/A
- 52 Week Low
- COSM $0.28
- RNXT $0.70
- 52 Week High
- COSM $1.32
- RNXT $1.69
- Technical
- Relative Strength Index (RSI)
- COSM 37.07
- RNXT 31.87
- Support Level
- COSM $0.70
- RNXT $0.91
- Resistance Level
- COSM $0.77
- RNXT $1.09
- Average True Range (ATR)
- COSM 0.08
- RNXT 0.09
- MACD
- COSM -0.01
- RNXT -0.02
- Stochastic Oscillator
- COSM 21.30
- RNXT 14.69
About COSM Cosmos Health Inc.
Cosmos Health Inc is engaged in the nutraceuticals sector through its own proprietary lines of products 'Sky Premium Life' and 'Mediterranation'. Additionally, the firm is operating in the pharmaceutical sector through the provision of a broad line of branded over-the-counter drugs and branded and generic medicines. The company's focus will be on Branded Pharmaceuticals, Over-the-Counter medicines, and Generic Pharmaceuticals. It provides its products to wholesale drug distributors, wholesalers, and retail healthcare providers. The company's segment are Wholesale, Pharma Manufacturing, Nutraceuticals & Pharmaceuticals and Other. It derives maximum revenue from Wholesale Segment.
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.